Cysteine proteases: Modes of activation and future prospects as pharmacological targets

Proteolytic enzymes are crucial for a variety of biological processes in organisms ranging from lower (virus, bacteria and parasite) to the higher organisms (mammals). Proteases cleave proteins into smaller fragments by catalyzing peptide bonds hydrolysis. Proteases are classified according to their...

Full description

Bibliographic Details
Main Authors: Sonia eVerma, Rajnikant eDixit, Kailash C Pandey
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00107/full
_version_ 1818959261011542016
author Sonia eVerma
Rajnikant eDixit
Kailash C Pandey
author_facet Sonia eVerma
Rajnikant eDixit
Kailash C Pandey
author_sort Sonia eVerma
collection DOAJ
description Proteolytic enzymes are crucial for a variety of biological processes in organisms ranging from lower (virus, bacteria and parasite) to the higher organisms (mammals). Proteases cleave proteins into smaller fragments by catalyzing peptide bonds hydrolysis. Proteases are classified according to their catalytic site, and distributed into four major classes: cysteine proteases, serine proteases, aspartic proteases and metallo-proteases. This review will cover only cysteine proteases, papain family enzymes which are involved in multiple functions such as extracellular matrix turnover, antigen presentation, processing events, digestion, immune invasion, hemoglobin hydrolysis, parasite invasion, parasite egress and processing surface proteins. Therefore, they are promising drug targets for various diseases. For preventing unwanted digestion, cysteine proteases are synthesized as zymogens, and contain a pro-domain (regulatory) and a mature domain (catalytic). The prodomain acts as an endogenous inhibitor of the mature enzyme. For activation of the mature enzyme, removal of the prodomain is necessary and achieved by different modes. The pro-mature domain interaction can be categorized as protein-protein interactions (PPIs) and may be targeted in a range of diseases. Cysteine protease inhibitors are available that can block the active site but no such inhibitor available yet that can be targeted to block the pro-mature domain interactions and prevent it activation. This review specifically highlights the modes of activation (processing) of papain family enzymes, which involve auto-activation, trans-activation and also clarifies the future aspects of targeting PPIs to prevent the activation of cysteine proteases.
first_indexed 2024-12-20T11:38:49Z
format Article
id doaj.art-0b3fd7bfffac4e41bd8e9aa30f0c4528
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-20T11:38:49Z
publishDate 2016-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-0b3fd7bfffac4e41bd8e9aa30f0c45282022-12-21T19:42:02ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122016-04-01710.3389/fphar.2016.00107193290Cysteine proteases: Modes of activation and future prospects as pharmacological targetsSonia eVerma0Rajnikant eDixit1Kailash C Pandey2National Institute of Malaria ResearchNational Institute of Malaria ResearchNational Institute for Research in Environmental HealthProteolytic enzymes are crucial for a variety of biological processes in organisms ranging from lower (virus, bacteria and parasite) to the higher organisms (mammals). Proteases cleave proteins into smaller fragments by catalyzing peptide bonds hydrolysis. Proteases are classified according to their catalytic site, and distributed into four major classes: cysteine proteases, serine proteases, aspartic proteases and metallo-proteases. This review will cover only cysteine proteases, papain family enzymes which are involved in multiple functions such as extracellular matrix turnover, antigen presentation, processing events, digestion, immune invasion, hemoglobin hydrolysis, parasite invasion, parasite egress and processing surface proteins. Therefore, they are promising drug targets for various diseases. For preventing unwanted digestion, cysteine proteases are synthesized as zymogens, and contain a pro-domain (regulatory) and a mature domain (catalytic). The prodomain acts as an endogenous inhibitor of the mature enzyme. For activation of the mature enzyme, removal of the prodomain is necessary and achieved by different modes. The pro-mature domain interaction can be categorized as protein-protein interactions (PPIs) and may be targeted in a range of diseases. Cysteine protease inhibitors are available that can block the active site but no such inhibitor available yet that can be targeted to block the pro-mature domain interactions and prevent it activation. This review specifically highlights the modes of activation (processing) of papain family enzymes, which involve auto-activation, trans-activation and also clarifies the future aspects of targeting PPIs to prevent the activation of cysteine proteases.http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00107/fulltrans-activationprotein-protein interactionPH sensorZymogenProdomainAuto-catalysis
spellingShingle Sonia eVerma
Rajnikant eDixit
Kailash C Pandey
Cysteine proteases: Modes of activation and future prospects as pharmacological targets
Frontiers in Pharmacology
trans-activation
protein-protein interaction
PH sensor
Zymogen
Prodomain
Auto-catalysis
title Cysteine proteases: Modes of activation and future prospects as pharmacological targets
title_full Cysteine proteases: Modes of activation and future prospects as pharmacological targets
title_fullStr Cysteine proteases: Modes of activation and future prospects as pharmacological targets
title_full_unstemmed Cysteine proteases: Modes of activation and future prospects as pharmacological targets
title_short Cysteine proteases: Modes of activation and future prospects as pharmacological targets
title_sort cysteine proteases modes of activation and future prospects as pharmacological targets
topic trans-activation
protein-protein interaction
PH sensor
Zymogen
Prodomain
Auto-catalysis
url http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00107/full
work_keys_str_mv AT soniaeverma cysteineproteasesmodesofactivationandfutureprospectsaspharmacologicaltargets
AT rajnikantedixit cysteineproteasesmodesofactivationandfutureprospectsaspharmacologicaltargets
AT kailashcpandey cysteineproteasesmodesofactivationandfutureprospectsaspharmacologicaltargets